Stocks Health care HEPA
OTC · Health careHepion Pharmaceuticals, Inc. (HEPA)
It posted a net loss of $3.2M. At June 30, 2026 it held $1.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Watch HEPA in 60 secondsWhat Hepion Pharmaceuticals, Inc. does
Hepion Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker HEPA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$8.3M | -$0.88 | n/a |
| 2024 | n/a | -$13.2M | -$107.35 | n/a |
| 2023 | $0 | -$48.9M | -$616.07 | -$40.9M |
| 2022 | $0 | -$42.2M | -$595.07 | -$35M |
| 2021 | $0 | -$32.7M | -$474.04 | -$31.4M |
| 2020 | $0 | -$20.4M | -$2,118.04 | -$16.3M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Hepion Pharmaceuticals, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 16, 2026Activist stake changed SCHEDULE 13D/A
- September 15, 2026Passive stake (5% or more) SCHEDULE 13G
- September 10, 2026Form DEF 14C filing DEF 14C
- September 8, 2026
- August 31, 2026Form PRE 14C filing PRE 14C
- August 27, 2026
- August 20, 2026
- August 20, 2026Activist stake changed SCHEDULE 13D/A
- August 20, 2026Activist stake (5% or more) SCHEDULE 13D
- August 20, 2026Activist stake (5% or more) SCHEDULE 13D
Insider trades
What the people running Hepion Pharmaceuticals, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns HEPA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vincent LoPriore13D, may seek influence with 2 related filers | 26.2% | August 20, 2026 |
| Black Global 5 LLC13D, may seek influence with 2 related filers | 11.1% | August 7, 2026 |
| KI Holdings Ltd.13D, may seek influence | 10.2% | September 16, 2026 |
| Gary Stetz13D, may seek influence | 5.7% | August 20, 2026 |
| Kenneth Rickel13G, passive | 5.7% | September 15, 2026 |
| Sireesh Appajosyula13D, may seek influence | 5.7% | August 20, 2026 |
Largest institutional holders
Insiders
Questions about HEPA
What does Hepion Pharmaceuticals, Inc. do?
Hepion Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker HEPA.
Is Hepion Pharmaceuticals, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $3.2M.
When did Hepion Pharmaceuticals, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake changed from September 16, 2026.
Similar companies
Compare HEPA with
Follow HEPA
Get an email when Hepion Pharmaceuticals, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow HEPA: get an email when it filesWhere the numbers come from
Financial figures are the values Hepion Pharmaceuticals, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.